# US Radiotherapy Market

> United States Radiotherapy Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals, Cancer Research Centers, Outpatient Facilities) By Technology (External Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy, Intensity-Modulated Radiation Therapy, Stereotactic Radiosurgery) By Applications (Oncology, Palliative Care, Preoperative, Postoperative, Curative Treatment) By Treatment Type (Conventional Radiotherapy, Radiotherapy for Targeted Therapy, Combination Therapy) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.89%
- **2024:** $ 2,250 Million
- **2025:** $ 2,472.53 Million
- **2035:** $ 6,350 Million
- **Key Players:** Varian Medical Systems (US), Elekta AB (SE), Siemens Healthineers (DE), Accuray Incorporated (US), Philips Healthcare (NL), GE Healthcare (US), Ion Beam Applications (BE), CIVCO Medical Solutions (US)

**Report ID:** MRFR/MED/16464-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-radiotherapy-market-17992

---

## Market Summary

## US Radiotherapy Market Highlighted Trends & Dynamics

The higher rate of cancer in the US is a big reason why so many people need treatment. Cancer is one of the main causes of illness and death, so the need for effective and focused cancer care has raised the demand for radiotherapy as a key treatment method.

Cancer screening programs and more people knowing about the disease are driving up the demand for radiotherapy. More people are being found with cancer at times that can be treated thanks to programs that encourage early discovery. This has raised the need for treatment as part of full cancer care. The growing number of older people is making chemotherapy more popular. As people age, the number of cases of cancer goes up.

The need for radiotherapy matches up with more personalized and accurate medical methods. Thanks to progress in genetics and molecular analysis, specific features of tumors can now be identified. This means that radiation treatments can be tailored to more precisely target cancer cells while protecting healthy organs.

A lot of people with different kinds of cancer want to get radiotherapy. Radiotherapy is a flexible and successful way to treat a wide range of tumors, from common types of cancer like breast, lung, and prostate cancer to less common types. Putting money into cancer facilities affects the need for radiotherapy. Cancer centers and healthcare institutions are always buying new radiotherapy equipment. This gives patients access to cutting-edge technologies and creates an ideal setting for providing excellent cancer care.

There is a lot of demand for radiation in the fields of pediatric medicine and treating children cancer. Radiotherapy is a big part of treating pediatric cancer as a whole, and new technologies are trying to make it less harmful to growing tissues so that young patients have better results.

Awareness campaigns about radiation safety help to meet the demand for radiotherapy. Sharing information about radiotherapy's benefits and safety steps with the public and healthcare workers helps people have a better understanding of its role in treating cancer.

Supportive care and managing symptoms are both things that people need from treatment. People with severe or fatal cancers can get palliative care through radiotherapy, which eases their symptoms and improves their quality of life.

## Market Drivers

### Increasing Cancer Incidence

The rising incidence of cancer in the US is a primary driver for the radiotherapy market. According to the American Cancer Society, approximately 1.9 million new cancer cases are expected to be diagnosed in 2025. This alarming trend necessitates advanced treatment options, including radiotherapy, which is often a critical component of cancer management. As the population ages and lifestyle factors contribute to higher cancer rates, the demand for effective radiotherapy solutions is likely to increase. This growing patient population is expected to propel investments in radiotherapy technologies and facilities, thereby enhancing the overall radiotherapy market. Furthermore, the increasing awareness of early cancer detection and treatment options is likely to further stimulate market growth.

### Growing Awareness and Education

Increasing awareness and education regarding cancer treatment options are driving the [radiotherapy market](../../../reports/radiotherapy-market-1526). Public health campaigns and educational initiatives are informing patients about the benefits of radiotherapy as a treatment modality. As more individuals become aware of the effectiveness of radiotherapy in managing various cancers, the demand for these services is expected to rise. In 2025, surveys indicate that nearly 70% of patients diagnosed with cancer are likely to consider radiotherapy as part of their treatment plan. This heightened awareness is fostering a more informed patient population, which is likely to lead to increased consultations and treatment uptake in the radiotherapy market. As a result, healthcare providers may need to enhance their service offerings to meet this growing demand.

### Government Initiatives and Funding

Government initiatives aimed at improving cancer care are playing a crucial role in the radiotherapy market. Federal and state programs are increasingly allocating funds to enhance cancer treatment infrastructure and research. For instance, the National Cancer Institute (NCI) has been instrumental in funding innovative research projects that focus on improving radiotherapy techniques. In 2025, government funding for cancer research is anticipated to exceed $6 billion, which is likely to benefit the radiotherapy market significantly. These initiatives not only support the development of new technologies but also aim to increase access to radiotherapy services across diverse populations. As a result, the radiotherapy market is expected to experience growth driven by enhanced funding and support from government entities.

### Rising Demand for Outpatient Services

The shift towards outpatient treatment models is influencing the radiotherapy market. Patients increasingly prefer outpatient services due to their convenience and reduced hospital stays. This trend is supported by advancements in radiotherapy techniques that allow for shorter treatment durations and improved patient management. As of 2025, it is estimated that outpatient radiotherapy services will account for over 60% of total treatments administered in the US. This shift not only enhances patient satisfaction but also reduces healthcare costs, making radiotherapy more accessible. Consequently, the radiotherapy market is likely to expand as healthcare providers adapt to this demand for outpatient services, leading to the establishment of more outpatient radiotherapy centers.

### Advancements in Radiotherapy Technology

Technological innovations are significantly shaping the radiotherapy market. The introduction of advanced treatment modalities, such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), has improved treatment precision and patient outcomes. These technologies allow for targeted delivery of radiation, minimizing damage to surrounding healthy tissues. As of 2025, the market for radiotherapy equipment is projected to reach approximately $7 billion, driven by the demand for state-of-the-art treatment options. Additionally, the integration of artificial intelligence and machine learning in treatment planning is expected to enhance the efficiency and effectiveness of radiotherapy, further propelling the market. The continuous evolution of technology in this field indicates a robust growth trajectory for the radiotherapy market.

## Future Outlook

The [Radiotherapy Market](https://www.marketresearchfuture.com/reports/radiotherapy-market-1526) is projected to grow at a 9.89% CAGR from 2025 to 2035, driven by technological advancements, increasing cancer prevalence, and enhanced treatment accessibility.

**New opportunities:**

- Development of AI-driven treatment planning software Expansion of tele-radiotherapy services Investment in portable radiotherapy devices for rural healthcare

By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment paradigms and increased patient access.

## Segment Insights

### By Technology: External Beam Radiotherapy (Largest) vs. Stereotactic Radiosurgery (Fastest-Growing)

The US radiotherapy market shows a diverse distribution of technologies, with External Beam Radiotherapy commanding a significant share due to its widespread adoption. Other segments such as Brachytherapy and Intensity-Modulated Radiation Therapy also contribute meaningfully, but the large-scale usage of External Beam techniques underscores its dominance. Brachytherapy is primarily utilized in specific cancer types, while Systemic Radiotherapy has a crucial role in treating advanced malignancies, albeit with a smaller market share.

Growth trends indicate that Stereotactic Radiosurgery is emerging as the fastest-growing segment, driven by advancements in technology and increased demand for precision treatments. Factors such as rising cancer incidences, technological innovations, and minimal side effects associated with these therapies are propelling market growth. Additionally, the increasing adoption of IMRT and innovative devices enhances treatment effectiveness, making these technologies key players in the evolving landscape of cancer management.

External Beam Radiotherapy (Dominant) vs. Stereotactic Radiosurgery (Emerging)

External Beam Radiotherapy stands out as the dominant technology in the US radiotherapy market, being favored for its versatility and applicability across various cancer types. It encompasses different techniques, including 3D conformal radiation therapy and advanced IMRT, allowing for tailored treatment plans that focus on minimal damage to surrounding healthy tissues. In contrast, Stereotactic Radiosurgery, characterized by its precision and ability to target tumors with high doses of radiation in fewer sessions, is rapidly gaining traction as an emerging technology. Its effectiveness in treating small and localized tumors makes it attractive, particularly in neurosurgery and oncology settings, leading to a notable shift toward its adoption in clinical practices.

### By Application: Oncology (Largest) vs. Palliative Care (Fastest-Growing)

The US radiotherapy market showcases a diverse application segment, with Oncology holding the largest market share. This segment benefits from increasing incidences of cancer, driving demand for advanced treatment options. Palliative Care, while smaller than Oncology, is experiencing rapid growth as the focus shifts towards patient comfort and quality of life, reflecting changing healthcare paradigms.

Growth trends in the US radiotherapy market are influenced by several factors, including technological advancements and increasing healthcare expenditure. The Oncology segment is continuously evolving with innovations in treatment methods, while Palliative Care is gaining traction due to an aging population and growing awareness about end-of-life care. The demand for efficient and effective treatment options further propels these segments forward.

Oncology (Dominant) vs. Palliative Care (Emerging)

Oncology is the dominant application in the US radiotherapy market, characterized by a robust demand for treatment modalities aimed at various cancer types. This segment benefits from continuous research and advancements in radiation technology, leading to improved therapeutic outcomes. On the other hand, Palliative Care is emerging as a critical segment, focusing on enhancing the quality of life for patients with serious illnesses. Its growth is fueled by a growing emphasis on compassionate care and patient-centered approaches, which advocate for treatment protocols that prioritize both effectiveness and the patients' comfort.

### By End Use: Hospitals (Largest) vs. Cancer Research Centers (Fastest-Growing)

In the US radiotherapy market, hospitals are the largest segment, significantly dominating the market share due to their comprehensive facilities and advanced treatment options. They provide a wide range of radiotherapy services catering to a large volume of patients. In contrast, cancer research centers, although smaller in overall share, are rapidly gaining traction. These centers focus on innovative treatments and clinical trials, attracting funding and partnerships that enhance their market presence.

The growth trends in the US radiotherapy market are largely driven by technological advancements and increasing cancer prevalence. As hospitals continue to upgrade their equipment and adopt more efficient radiotherapy techniques, they remain a stable and significant player in the market. Conversely, cancer research centers are emerging as key players, propelled by their focus on research and development, which leads to faster adoption of cutting-edge therapies, making them the fastest-growing segment.

Hospitals (Dominant) vs. Cancer Research Centers (Emerging)

Hospitals serve as the dominant force in the US radiotherapy market by offering an extensive array of treatment types and facilities. Their size and resource availability enable them to cater to a large patient base, providing critical services that include both traditional and advanced radiotherapy options. In comparison, cancer research centers are emerging as pivotal contributors to the market; they specialize in groundbreaking research aimed at refining radiotherapy approaches and enhancing treatment efficacy. The adaptation and implementation of novel therapies in these centers often lead to improved patient outcomes, establishing them as significant players that complement and challenge traditional hospital settings.

### By Treatment Type: Conventional Radiotherapy (Largest) vs. Combination Therapy (Fastest-Growing)

The US radiotherapy market showcases a diverse array of treatment types, with Conventional Radiotherapy leading in market share due to its established efficacy and widespread acceptance among practitioners. This segment benefits from a robust infrastructure of healthcare facilities and trained personnel, securing its position as the dominant force in the market. In contrast, Combination Therapy is making significant inroads, leveraging advancements in technology that allow for synergistic effects when used alongside traditional methods.

Growth in the Treatment Type segment is driven by increasing cancer prevalence, which fuels demand for effective treatment solutions. Targeted therapies are gaining traction, focusing on precision medicine that tailors treatment to individual patient profiles. Moreover, innovations in Combination Therapy that enhance effectiveness and reduce side effects contribute to its rapid expansion, positioning it as a vital option for future treatments in oncology.

Conventional Radiotherapy (Dominant) vs. Combination Therapy (Emerging)

Conventional Radiotherapy remains the dominant treatment type in the US radiotherapy market, characterized by its widespread use for various cancer types and a strong track record of clinical success. This method employs high doses of radiation to eradicate tumor cells, and its efficacy is supported by decades of research and clinical trials. On the other hand, Combination Therapy is an emerging approach that incorporates multiple modalities to optimize treatment outcomes. By integrating Conventional Radiotherapy with immunotherapy or targeted therapies, Combination Therapy aims to enhance the overall effectiveness while mitigating potential side effects. This innovative strategy is garnering interest for its ability to address complex cancer cases, suggesting a transformative shift in treatment paradigms as the market evolves.

## Competitive Benchmarking

The radiotherapy market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on personalized treatment options. Key players such as Varian Medical Systems (US), Elekta AB (SE), and Accuray Incorporated (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Varian Medical Systems (US) focuses on integrating artificial intelligence (AI) into its treatment planning systems, which appears to streamline workflows and improve patient outcomes. Meanwhile, Elekta AB (SE) emphasizes its commitment to sustainability, aiming to reduce its carbon footprint through eco-friendly manufacturing processes and energy-efficient products. These strategies collectively foster a competitive environment that prioritizes technological innovation and sustainability. In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain resilience and reduce operational costs. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of products and services, catering to various customer needs while driving innovation across the sector. In October 2025, Varian Medical Systems (US) announced a partnership with a leading AI firm to develop advanced algorithms for radiation therapy planning. This collaboration is poised to enhance treatment precision and reduce planning time, reflecting a broader trend towards integrating AI in healthcare. Such strategic moves not only bolster Varian's technological capabilities but also position it as a leader in the evolving landscape of radiotherapy. In September 2025, Accuray Incorporated (US) launched a new version of its CyberKnife system, which incorporates enhanced imaging capabilities and real-time tracking. This development is significant as it addresses the growing demand for more accurate and less invasive treatment options, potentially expanding Accuray's market share in the competitive landscape. The introduction of this technology underscores the company's commitment to innovation and patient-centric solutions. In August 2025, Elekta AB (SE) expanded its operations in North America by establishing a new manufacturing facility in the US. This strategic move is likely to enhance its production capacity and reduce lead times for customers, thereby strengthening its competitive position. The facility is expected to focus on developing next-generation radiotherapy solutions, aligning with the company's long-term growth strategy. As of November 2025, the radiotherapy market is increasingly defined by trends such as digitalization, sustainability, and AI integration. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing product offerings. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological advancements, reliability in supply chains, and the ability to deliver personalized treatment solutions. This transition may redefine market dynamics, emphasizing the importance of innovation and strategic partnerships in maintaining a competitive edge.

## Report Scope

| MARKET SIZE 2024 | 2250.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 2472.53(USD Million) |
| MARKET SIZE 2035 | 6350.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.89% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Varian Medical Systems (US), Elekta AB (SE), Siemens Healthineers (DE), Accuray Incorporated (US), Philips Healthcare (NL), GE Healthcare (US), Ion Beam Applications (BE), CIVCO Medical Solutions (US) |
| Segments Covered | Technology, Application, End Use, Treatment Type |
| Key Market Opportunities | Integration of artificial intelligence in treatment planning enhances precision in the radiotherapy market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive competitive dynamics in the radiotherapy market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US radiotherapy market in 2024?**
A: The overall market valuation was $2250.0 Million in 2024.

**Q: What is the projected market valuation for the US radiotherapy market by 2035?**
A: The projected valuation for 2035 is $6350.0 Million.

**Q: What is the expected CAGR for the US radiotherapy market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during the forecast period 2025 - 2035 is 9.89%.

**Q: Which companies are considered key players in the US radiotherapy market?**
A: Key players include Varian Medical Systems, Elekta AB, Siemens Healthineers, Accuray Incorporated, Philips Healthcare, GE Healthcare, Ion Beam Applications, and CIVCO Medical Solutions.

**Q: What are the main technology segments in the US radiotherapy market?**
A: Main technology segments include External Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy, Intensity-Modulated Radiation Therapy, and Stereotactic Radiosurgery.

**Q: How does the valuation of External Beam Radiotherapy compare to other segments?**
A: External Beam Radiotherapy has a valuation range of $900.0 Million to $2500.0 Million, making it one of the largest segments.

**Q: What applications are driving growth in the US radiotherapy market?**
A: Key applications include Oncology, Palliative Care, Preoperative, Postoperative, and Curative Treatment.

**Q: What is the valuation range for the Outpatient Facilities segment in the US radiotherapy market?**
A: The valuation range for Outpatient Facilities is $750.0 Million to $2050.0 Million.

**Q: What treatment types are included in the US radiotherapy market?**
A: Treatment types include Conventional Radiotherapy, Radiotherapy for Targeted Therapy, and Combination Therapy.

**Q: How do the valuations of Cancer Research Centers compare to Hospitals in the US radiotherapy market?**
A: Cancer Research Centers have a valuation range of $600.0 Million to $1800.0 Million, while Hospitals range from $900.0 Million to $2500.0 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-radiotherapy-market-17992*